Equity · Healthcare
NVAX
NASDAQNovavax (NVAX)
The line runs $7.37 on 28 July through $9.69 on 23 October, on a scale from $6 to $14. Days the market did not trade hold the previous close, flat.
- Market cap
- $1.6B
- 52-week range
- $6.22 – $12.85
- Avg volume
- 496.1K
- Mentions, 30 days
- 16
- Net sentiment
- +0.09
as of Oct 23, 2026
Have Novavax (NVAX) insiders bought or sold shares recently?
NVAX has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 20 June 2026.
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 20 Jun 2026 | Rodgers Richard JDirector | Option exercise | 18,880 | |
| 20 Jun 2026 | King Rachel K.Director | Option exercise | 18,880 | |
| 20 Jun 2026 | DOUGLAS RICHARDDirector | Option exercise | 18,880 | |
| 20 Jun 2026 | MCGLYNN MARGARET GDirector | Option exercise | 18,880 | |
| 20 Jun 2026 | MOTT DAVID MDirector | Option exercise | 18,880 | |
| 20 Jun 2026 | Alton Gregg HDirector | Option exercise | 18,880 | |
| 25 Apr 2026 | Newton Charles W.Director | Option exercise | 9,520 | |
| 10 Mar 2026 | Shiver John W.Director | Option exercise | 7,947 | |
| 07 Mar 2026 | Kelly James PatrickEVP, CFO and Treasurer | Option exercise | 12,223 | |
| 07 Mar 2026 | Kelly James PatrickEVP, CFO and Treasurer | Tax withheld | 5,904 | $59K |
| 03 Mar 2026 | Kelly James PatrickEVP, CFO and Treasurer | Option exercise | 43,167 | |
| 03 Mar 2026 | Kelly James PatrickEVP, CFO and Treasurer | Tax withheld | 20,850 | $198K |
Showing the 12 most recent of 36 compensation filings in this window. The figures above count all of them.
Which funds hold Novavax (NVAX)?
11 of the 45 institutional funds we track reported a Novavax position for the quarter ended 30 Jun 2026 — a combined $188.1M; the latest of those filings landed 02 Sep 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| D. E. Shaw & Co. | Trimmed | 5,650,905 | $53.2M | −26.7% |
| Two Sigma Investments | Added | 4,091,043 | $38.5M | +565.4% |
| Coatue Management | Held (±25%) | 3,836,986 | $36.1M | |
| Millennium Management | Trimmed | 1,768,163 | $16.7M | −54.1% |
| Citadel Advisors | Added | 1,695,313 | $16.0M | +50.9% |
| AQR Capital Management | Added | 902,650 | $8.5M | +705.5% |
| Point72 Asset Management | Trimmed | 664,286 | $6.3M | −56.2% |
| Marshall Wace | Trimmed | 652,773 | $6.1M | −44.0% |
| Renaissance Technologies | Held (±25%) | 501,783 | $4.7M | +0.9% |
| Tudor Investment Corp | Held (±25%) | 125,468 | $1.2M | −2.6% |
Showing the 10 largest of 11 reported positions. The figures above count all of them.
What has been filed or recorded for Novavax (NVAX)?
The filings we hold for Novavax, newest first: 4 fails-to-deliver days, 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 25 Sep 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 25 Sep 2026 | Fails to deliver | Shares failed to deliver | 369 shares | $4K notional · <0.001% of shares out |
| 22 Sep 2026 | Fails to deliver | Shares failed to deliver | 58,330 shares | $607K notional · 0.035% of shares out |
| 18 Sep 2026 | Fails to deliver | Shares failed to deliver | 4,908 shares | $49K notional · 0.003% of shares out |
| 11 Sep 2026 | Fails to deliver | Shares failed to deliver | 11 shares | $102 notional · <0.001% of shares out |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS −$0.32 | Revenue $57M |
| 30 Jun 2026 | Financials | Total assets | $955.6M | at period end |
| 30 Jun 2026 | Financials | Total equity | −$190.7M | at period end |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS −$0.06 | Revenue $140M |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS $2.58 | Revenue $1.12B |
| 31 Dec 2025 | Financials | Revenue | $1.1B | fiscal year |
| 31 Dec 2025 | Financials | Net income | $440.3M | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | $2.58 | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS −$1.25 | Revenue $70M |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS $0.62 | Revenue $239M |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS $2.93 | Revenue $667M |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS −$1.23 | Revenue $682M |
| 30 Sep 2024 | Quarterly earnings | Q3 2024 reported | EPS −$0.76 | Revenue $85M |
What is Reddit saying about Novavax (NVAX)?
Reddit mentioned NVAX 16 times in the 30 days to 26 October 2026, across 2 of the communities we track. All of them were scored for sentiment: 63% read bullish, 6% bearish and 31% neither. Reddit data updated 26 October 2026.
30-day window, Method
Mentions, 30 days 16Bullish 63%Bearish 6%Communities 2Against the market +9 points
How do Reddit mentions of Novavax (NVAX) compare with its price?
Share ↗
bullish
bullish
NVAX reads 9 points more bullish than overall market sentiment. Same measure; same 30-day window.
Where Novavax (NVAX) is discussed
30 days
| Community | Share | Mentions | Net sentiment |
|---|---|---|---|
| r/wallstreetbets | 94% | 15 | +0.10 |
| r/options | 6% | 1 | +0.02 |
Novavax (NVAX): frequently asked questions
What did Novavax shares close at?
Novavax closed at $9.69 on 23 Oct 2026, down 3.00% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Novavax’s market cap?
Novavax is worth $1.6B by market value as of 23 Oct 2026, which is the share price times the shares on issue from its SEC filings.
What is Novavax’s revenue?
Novavax reported revenue of $1.1B for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Novavax insiders bought or sold shares recently?
No Novavax insider has filed a Form 4 in the last 90 days; the most recent filing we hold is dated 20 Jun 2026 (SEC Form 4). See Insiders
Which funds own Novavax?
11 of the 45 funds we track reported a Novavax position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were D. E. Shaw & Co., Two Sigma Investments and Coatue Management. See Funds
When did Novavax last report earnings?
Novavax last reported earnings on 30 Jun 2026 for Q2 2026, with EPS of −$0.32; no next date is announced in SEC filings yet. See Filings
What is Reddit saying about Novavax?
Novavax was mentioned 0 times in the last 7 days across the finance subreddits we track, and 16 times over the trailing 30 days. Of the 16 mentions scored for sentiment, 63% read bullish and 6% bearish. That is a social signal, not investment advice. See Reddit
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- RedditReddit ingest across the tracked finance subreddits
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- SECSEC fails-to-deliver (CNS) data
- SEC EDGARXBRL company facts, latest period ended 30 Jun 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings